Health & Fitness Inhaled steroid to be trialled as a potential at-home treatment for coronavirus

An inhaled steroid will be investigated as a possible treatment for coronavirus as part of a national trial.

© Peter Byrne Inhaled steroid to be trialled as a possible at-home treatment for coronavirus (Peter Byrne/PA)

Budesonide will form part of the UK’s priority platform trial for Covid-19 treatments that can be taken at home.

Led by the University of Oxford, the Principle (Platform Randomised trial of INterventions against Covid-19 In older peoPLE) trial is evaluating treatments that can help people aged over 50 recover more quickly from coronavirus and prevent the need for hospital admission.

What should I know before using prednisolone?

Find out the most important things to be aware of when taking this steroid medicineIt's important that you don't stop taking prednisolone suddenly if you've been taking it every day for more than three weeks (sometimes less - your doctor will advise). Long-term use of prednisolone can stop your adrenal glands producing natural corticosteroids (this is called adrenal suppression), which means that your body becomes temporarily reliant on the medicine.

Treatment gets results for serious cases in China and Japan, but use of the drugs is discouraged. TOKYO—Some doctors in China and Japan are using steroid drugs to treat coronavirus patients with Steroids in general tamp down inflammation, so they come to mind when doctors are trying to

A potential treatment for coronavirus using blood from recovered patients is to be trialled in the UK after thousands showed interest in the scheme. Antibodies are developed by the immune system to attack a foreign invasion such as an illness, though it is not known how much they build up in people

Inhaled corticosteroid budesonide is commonly prescribed as part of the long-term management of asthma and chronic obstructive pulmonary disease with no serious side-effects associated with short-term use.

In some patients with Covid-19, the body mounts a significant immune response to fight the virus, causing high levels of inflammation that can damage human cells in the airways and lungs.

Research suggests inhaling budesonide into the airways targets anti-inflammatory treatment where it is needed most and can potentially minimise any lung damage that might otherwise be caused by the virus.

Sars-CoV-2, the virus that causes Covid-19,  binds to ACE2 receptors lining cells in the airways, gaining entry to human cells and replicating within.

Dexamethasone: a steroid medicine

Everything you need to know about treatment with this corticosteroid medicine, including treating COVID-19They are often referred to as steroids. Dexamethasone is a generic medicine, available as tablets, liquid, eye drops and injection.

Treating Coronavirus at Home . The coronavirus (COVID-19) sounds scary, and for some people If you must share a bathroom, it will have to be cleaned for coronavirus after each use. Read More: Coronavirus Facts: Medicines and Treatment . What you can do is treat the symptoms so that you

At least 10 clinical trials are currently looking at the potential use of chloroquine as an option for combating the novel coronavirus . If you’re young and healthy with only mild symptoms, your doctor will likely advise you to isolate yourself at home and to limit contact with others in your household.

Gallery: Anti-vaxx: Are these diseases making a comeback? (Espresso)

Laboratory studies suggest inhaled corticosteroids reduce the number of these receptors in the airways and so may block entry of the virus into human cells.

Professor Chris Butler at the University of Oxford, who led the Principle trial, said: “Budesonide is relatively inexpensive, safe and easy-to-administer drug for respiratory conditions that may have a role to play in treating Covid-19.

“It is only through enrolling volunteers on a randomised controlled trial like Principle that we can assess whether there are clear benefits or harms associated with potential treatments like budesonide.

“We need many more volunteers to join the trial so we can get the answers we really need to keep people with Covid-19 out of hospital.

“Like vaccines and preventative measures, treatments have an important role to play in minimising the burden of this disease on society.”

Trial participants will be randomly assigned to receive an inhaler in the post and the usual standard-of-care from their clinician.

They will be asked to inhale two puffs twice a day for 14 days with each puff providing a 400 microgram dose of budesonide.

They will be followed-up for 28 days and will be compared with participants who have been assigned to receive the usual standard-of-care only.